First ENKORE Policy Brief published
The ENKORE cluster published its first policy brief on endocrine disrupting chemicals. The policy brief outlines science-based recommendations to: ENKORE is a cluster of five research projects from the call HORIZON-HLTH-2023-ENVHLTH-02-03 “Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties”. The cluster aims to strengthen collaboration, avoid duplication and increase the […]
Second EDC-MASLD Policy Forum on Chemical Mixtures and Regulatory Inefficiencies

We are pleased to announce the Second EDC-MASLD Policy Forum, which will be held online on 5 February 2026, from 10:00 to 12:00 CET. This online forum will bring together experts from science, regulatory authorities, and industry to address the complex issues surrounding chemical mixtures and regulatory inefficiencies. Key Information: This forum will feature a […]
Press release: Fondation Crédit Mutuel Alliance Fédérale joins EDC-MASLD project
The Foundation Crédit Mutuel Alliance Fédérale and the IHU ICAN formalised a four-year partnerhsip in support of the EDC-MASLD project on the 4 December, 2025 at the Pitié-Salpêtrière Hospital, Paris. The funding covers a liver-dedicated MRI imageing module and MRI image ayquistion. This allows liver lesions to be monitored over time without biopsy. EDC-MASLD studies […]
Next Generation Risk Assessment of Emerging PFOA Alternatives
Contribution by You Song, Senior Research Scientist at NIVA and EDC-MASLD researcher EDC-MASLD is pleased to highlight a new publication by You Song in Environmental Science & Technology that explores how innovative New Approach Methodologies (NAMs) can support more efficient and ethical assessment of PFAS chemical risks. This work focuses on emerging alternatives to legacy PFAS […]
EDC-MASLD Presentation at the Italian Liver Foundation’s Yellow Webinar Series

On September 8th 2025, the EDC-MASLD project was featured in the Yellow Webinar Series organised by the Italian Liver Foundation. Dr. Stefania Carobbio, Principal Investigator at the Príncipe Felipe Research Center (CIPF) – our work package partner in the EDC-MASLD consortium, delivered a presentation titled “Effect of EDCs in the Progression of MASLD.” The webinar introduced the project and consortium, provided background […]
New Project Partner: IBISS
The Institute for Biological Research “Siniša Stanković” (IBISS), part of the University of Belgrade, has joined the EDC-MASLD consortium as a new partner. IBISS is Serbia’s leading multidisciplinary institution in the field of biological sciences, conducting fundamental and applied research across biochemistry, molecular biology, physiology, genetics, ecology, neurobiology, and environmental protection. Within Work Package 5, IBISS contributes its expertise in perinatal programming, […]
PFAStwin Public Lecture

Dr. Nataša Veličković, PI of the Institute for Biological Research “Siniša Stanković” (IBISS), was an invited speaker in the series of lectures organized within the PFAStwin project, with the aim of facilitating the exchange of knowledge and experience related to PFAS in Serbia. Her lecture entitled “The influence of PFAS on the development of metabolic […]
EDC-MASLD @ AISF 2025
Our PI Elisabetta Bugianesi and her team from the University of Turino will be presenting their work at the 57th Annual Meeting of the Italian Association for the Study of the Liver in Rome from 27-28 March 2025. Their presentation on the Impact of sexual dimorphism on liver damage in patients with metabolic-dysfunction associated steatotic […]
EDC-MASLD @ EASL SLD Summit
Our partner from the University of Turino will be presenting at the European Association for the Study of the Liver (EASL) SLD Summit from 23-25 January in Estoril (Portugal). The team around Prof. Elisabetta Bugianesi – Chiara Rosso, Gian Paolo Caviglia, and Eleonora Dileo – is going to present A targeted steroidomic approach to investigate the […]
EDC-MASLD Policy Forum: Appreciation and Insights

We are proud to announce the successful conclusion of our first EDC-MASLD Policy Forum, held on November 19, 2024, with over 60 participants, including experts from the ENKORE Cluster. This event was an essential platform for exchanging insights and aligning the latest scientific findings with regulatory strategies on endocrine-disrupting chemicals (EDCs). Key Highlights from the Forum: The forum […]